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ABSTRACT
Background: Invasion of extracellular matrix is a hallmark
of malignant tumors. Clamping maneuvers during cancer
surgery reduce blood loss, but trigger reperfusion injury
(RI). RI increases cancer recurrence in the reperfused or-
gan through up-regulation of matrix metalloproteinase-9
(MMP-9). Interleukin-8 is an important cytokine in RI pro-
moting accumulation of neutrophils, a major source of
MMP-9. Volatile anesthetics were demonstrated to reduce
RI. We hypothesized that these anesthetics might attenuate
MMP-9 up-regulation and consequently tumor cell invasion
in RI.
Methods: Isolated human neutrophils (n 6) were precon-
ditioned with sevoflurane or desflurane, followed by stimu-
lation with interleukin-8, phorbol myristate acetate, or
chemokine CXC-ligand 1 (CXCL1) to differentiate intracel-
lular pathways. MMP-9 release and activity were quanti-
fied by enzyme-linked immunosorbent assay and zymog-
raphy, respectively. CXC-receptor-2 (CXCR2) expression
and phosphorylation of extracellular signal-regulated kinases
1/2 were assessed by flow cytometry. The impact of MMP-9
on the invasion of neutrophils andMC-38 colon cancer cells
was assessed using Matrigel-coated filters (n 6).
Results: Preconditioning reduced interleukin-8-induced
MMP-9-release by 41% (13, 5%, sevoflurane) and 40%
(13%, desflurane). This was also evident following stimu-
lation of CXCR2 with CXCL1. No impact on phosphoryla-
tion of extracellular signal-regulated kinases 1/2 andMMP-9
release was observed with receptor-independent stimulation
of protein kinase C with phorbol myristate acetate. Precon-
ditioning reduced transmigration of neutrophils andMC-38
tumor cells to baseline levels.
Discussion: Volatile anesthetics impair neutrophil MMP-9
release and interfere with pathways downstream of CXCR2,
but upstream of protein kinase C. Through down-regulation
ofMMP-9, volatile anesthetics decreaseMatrigel breakdown
and reduce subsequent migration of cancer cells in vitro.
S URGICAL resection is the primary treatment for pa-tients suffering from colorectal cancer. For higher stages
of disease with tumor spread, surgical removal of isolated
liver metastases combined with chemotherapy is common
and may be curative in selected patients.1 The 5-yr survival
rate of such patients qualifying for curative liver resection is
40–50%, mostly because of recurrent malignancies within the
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What We Already Know about This Topic
• Matrix metalloproteinase-9 (MMP-9) facilitates tumor invasion
and migration by degrading extracellular matrix
• Neutrophil release of MMP-9 through protein kinase C (PKC)
activation is increased by interleukin-8 (IL-8) stimulation during
postischemia reperfusion
• Potent volatile anesthetics attenuate reperfusion injury and de-
crease up-regulation of stimulated neutrophil inflammatory ad-
herence molecules
What This Article Tells Us That Is New
• Volatile anesthetic preconditioning reduced MMP-9 release
by IL-8-stimulated human neutrophils in vitro
• This effect was mediated downstream of the IL-8 receptor and
upstream of PKC
• MMP-9 down-regulation reduced mouse colon carcinoma cell
migration across simulated extracellular matrix in vitro
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liver.1 This poor outcome might be partially influenced by the
hepatic resection itself. First, surgical manipulation leads to
the dissemination of cancer cells into the blood.2,3 Second,
clamping maneuvers to anticipate large blood losses are known
to result in reperfusion injury of the liver,4,5 which has been
shown to increase both the number and the size of liver
metastasis in animal models of colorectal cancer.4,6
There is a considerable amount of evidence that matrix
metalloproteinase-9 (MMP-9), also referred to as gelatinase
B, plays an important role at different steps of malignant
tumor growth.7 MMP-9 belongs to a family of zinc-depen-
dent gelatinases that degrades components of the extracellu-
lar matrix.8 Before invading blood or lymph vessels, malig-
nant tumor cells are obliged to cross multiple physical
barriers, such as the extracellular matrix.9 By degrading the
extracellular matrix, MMP-9 promotes this process and
facilitates tumor invasion and migration.7 Several other pro-
teinases are also able to degrade components of the extracel-
lular matrix. However, matrix metalloproteinases appear to
be of particular importance with specific members being pre-
dominant for certain malignant tumors.8 MMP-9 was dem-
onstrated to have a strong impact on colon cancer.7,10,11
Albeit the fact that tumor cells are able to produceMMP-9,
the richest source ofMMP-9 in the body are neutrophils. Neu-
trophils produce MMP-9 constitutively at a low basal rate and
dramatically increase MMP-9 release upon stimulation with
the proinflammatory cytokine interleukin-8 (IL-8).12 High
amounts of IL-8 are released during the reperfusion phase after
ischemia and promote the influx of large numbers of neutro-
phils into the reperfused organ.13–15 Volatile anesthetics were
demonstrated to attenuate reperfusion injury in vivo16–18 and to
decrease the up-regulation of inflammatory adherence mole-
cules of stimulated neutrophils in vitro.19–21
Therefore, we hypothesized that volatile anesthetics not
only attenuate up-regulation of cell surface molecules, but
also reduce the release of MMP-9, stored in neutrophil gran-
ules. This study further aims at investigating if volatile anes-
thetic-induced decreased levels of MMP-9 are functionally
potent enough to impair degradation of extracellular matrix
and subsequent invasion of tumor cells.
Materials and Methods
Isolation of Neutrophils
Citrated venous blood was collected after informed consent
from volunteers with no history of illness in the past 14 days.
Ethical approval was received from the Ethic Committee of
the University Hospital Zurich (Zurich, Switzerland). Red
blood cells were lysed and neutrophils were isolated by gra-
dient centrifugation as described before.22 The remaining
cell suspension was layered over Ficoll-Histopaque 1077
(Sigma-Aldrich, St. Louis, MO), centrifuged at 1,500 rpm
for 30 min, and resuspended at 2  106 neutrophils/ml in
Ham’s F-12medium supplementedwith 0.5%bovine serum
albumin (Invitrogen, Carlsbad, CA). All steps were per-
formed at 4°C to prevent artificial activation of neutrophils.
Before each experiment, neutrophils were examined under
the light microscope for signs of artificial activation such as
clumping, which were absent.
Preconditioning with Volatile Anesthetics
Neutrophil cell suspension was seeded in sterile 96-well
plates at 50 l per well (105 neutrophils/well) and placed in
humified airtight chambers (Oxoid anaerobic jar; Oxoid AG,
Basel, Switzerland). Chambers were flushed with an air/5%
CO2-mixture for 5 min that was optionally augmented with
2.2% of sevoflurane (Sevorane; Abbott AG, Baar, Switzer-
land, corresponding vaporizer: Sevotec5; Abbott AG) or
6% of desflurane (Forene; Baxter, Zurich, Switzerland; cor-
responding vaporizer: Tec6, Carbamed; Liebefeld, Switzer-
land). Control cells were exposed to the air/5%CO2-mixture
only. Volatile anesthetic concentrations were measured by
the Ohmeda 5330 Agent Monitor (Abbott AG). Chambers
were sealed and kept in an incubator (Bioblock, Ittingen,
Switzerland) at 37°C for 45min (preconditioning  expo-
sure to volatile anesthetic before stimulation). The concen-
trations of the volatile anesthetic were again checked at the
end of incubation to preclude insufficient sealing.
Stimulation of Neutrophils
Following preconditioning, neutrophils were removed from
the chambers and put in an incubator at 37°C flushed with
an air/5% CO2-mixture. Neutrophils were immediately
stimulated with 100 nM human IL-8 (recombinant human
IL-8, BDPharmingen, Franklin Lakes, NJ) for 15min. Neu-
trophils exposed to air/5% CO2-mixture during precondi-
tioning followed by stimulation with phosphate-buffered
saline served as negative controls. Stimulation was stopped
on ice and supernatants were harvested for further analysis.
For experiments on protein kinase C (PKC)-dependent
extracellular signal-regulated kinase (ERK) 1/2 phosphoryla-
tion and MMP-9 release, neutrophils were preconditioned
(see Preconditioning with Volatile Anesthetics), followed by
stimulation with 100 nM phorbol myristate acetate (PMA) for
5 min. Stimulation with the chemokine CXC-ligand 1
(CXCL1) at 100 ng/ml for 15 min was used in experiments to
trigger through CXC-receptor 2 (CXCR2) MMP-9-release.
Quantification of Total MMP-9 in Supernatant
Concentration of MMP-9 was determined using an enzyme-
linked immunosorbent assay (ELISA), according to manu-
facturer’s directions (R&D systems, Minneapolis, MN).
This assay measures the 92 kDa pro-MMP-9 and the 82 kDa
active MMP-9.
Measurement of Enzymatic Activity of MMP-9
Activity of MMP-9 in supernatants from IL-8- and PMA-
stimulated neutrophils was measured using zymography, as
described before.23 Zymography gels containing gelatin as a
substrate for MMP-9 were used. MMP-9 activity was indi-
rectly evaluated by quantification of the degraded amount of
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gelatin using densitometry. A control of human recombinant
MMP-9 (R&D Systems) was run with every gel together
with protein molecular marker (SeeBlue2, Invitrogen) to
confirm the MMP-9-band. Data were analyzed with ImageJ
(Wayne Rasband, Bethesda, MD).
Flow Cytometric Measurement of Neutrophil Viability
Unstimulated neutrophils were exposed to volatile anesthetics
(see Preconditioning with Volatile Anesthetics). Cells were har-
vested and incubated with the cell impermeable DNA-dye
7-aminoactinomycin (7-AAD,BDBiosciences, FranklinLakes,
NJ) for 20 min at room temperature and analyzed by flow
cytometry (FACS Canto II, BD Biosciences). Viable cells were
defined as staining negative for 7-AAD.
Flow Cytometric Measurement of PKC-dependent
ERK1/2 Phosphorylation
Following preconditioning (see Preconditioning with Vola-
tile Anesthetics), neutrophils were stimulated with 100 nM
PMA for 5min at 37°C. Staining of phosphorylated ERK1/2
was performed as previously described.24 We used an Al-
exa488-conjugated mouse antihuman pERK1/2 antibody
(Cell Signaling, Danvers, MA) at a final staining concentra-
tion of 0.05 g/ml and the appropriate isotype control.
Flow Cytometric Measurement of CXCR2 Expression
Neutrophils were exposed to volatile anesthetics (see Precon-
ditioning with Volatile Anesthetics). Following exposure for
45 min, they were stained on ice for 30 min with antibodies
reactive to IL-8 receptor CXCR2 (mouse antihuman
CXCR2 at a final staining concentration of 0.25 g/ml; BD
Biosciences). Appropriate isotype controls were run with ev-
ery experiment. 7-AAD serving as a dead/live-stain was in-
cluded in every sample, and only cells negative for 7-AAD
were included in the analysis.
Neutrophil Migration Assay with Matrigel
Filters of a 96-well migration plate with 8mpores (Millipore,
Billerica, MA) were coated with 10 l of pure Matrigel (BD
Biosciences). Matrigel is rich in collagen IV, laminin, and pro-
teoglycans, and is widely used to simulate the extracellular ma-
trix in vitro during invasion and migration.25–27 Neutrophil
were seeded in the upper compartment, preconditioned with
volatile anesthetics, and stimulatedwith IL-8 (see Stimulationof
Neutrophils). After stimulation for 15 min, 150 l of Ham’s
F-12 medium supplemented with 10% fetal calf serum (Invit-
rogen) was added to the lower compartment and neutrophils
were allowed tomigrate for 2 h at 37°C. Transmigrated neutro-
phils were quantified by endogenous -glucuronidase.28 For
each experiment, outliers that deviatedmore than one SD from
the mean of each experimental group were excluded.
MC-38GFP (Green Fluorescent Protein)/Mouse Neutrophil
Comigration Assay with Matrigel
Cell Culture of Mouse Neutrophils. In vitro differentiated
mouse granulocytes were generated as described before.29
Briefly, isolated bonemarrow cells were transfected withmu-
rine stem cell virus vector containing estrogen dependent
fusion oncoprotein (E2A-Pbx1-ER) that blocks myeloid dif-
ferentiation. Conditionally immortalized myeloid progeni-
tors were cultivated in the Roswell Park Memorial Institute
medium (Invitrogen) supplemented with granulocyte mac-
rophage colony-stimulating factor and 1 M -Estradiol.
On removal of estrogen, progenitor clones differentiated to
granulocytes andwere characterized with staining of CD11b,
Gr-1, and F4/80 antibodies.
Mouse colon carcinoma cell line MC-38GFP were grown in
Dulbecco’s Modified Eagle medium with 10% fetal calf serum.30
Doubling time ofMC-38GFP in culture is approximately 12 h.
Migration. Mouse neutrophils (2  105) were seeded on
Matrigel-coated 24-well migration plates with 8 m pores
(BD Biosciences) and preconditioned with volatile anesthet-
ics (as described for human granulocytes in Preconditioning
with Volatile Anesthetics). Stimulation was performed with
100 ng/ml CXCL1 (recombinantmouse CXCL1, R&DSys-
tems) for 15 min. Starved MC-38GFP cells (2  104) were
then added to the granulocytes. Medium containing 10%
fetal calf serum served as unspecific chemoattractant and was
added to the lower compartment. Cells were allowed tomigrate
for 6 h at 37°C in an incubator free of volatile anesthetics.
Analysis. Nonmigrated cells were removed from the upper
chamber with a cotton swab. Filters were fixed with parafor-
maldehyde and stained with diamidinophenylindole. Six-
teen automatically randomized pictures of each sample were
taken on a Leica LX microscope (Leica, Buffalo Grove, IL)
and GFP/diamidinophenylindole cells counted. Data are
given as total number of migrated cells.
Statistical Analysis
All experiments were performed at least three times with
blood from different donors. For experiments with n 6 or
more for each condition, normal distribution was assessed
using the Kolmogorov–Smirnov-test. Normally distributed
values were expressed as mean  SD and analyzed using
one-way ANOVA with a Bonferroni post hoc correction to
reduce the probability of a type I error. For zymography
experiments with n  3 for each condition, nonparametric
testing with Kruskall-Wallis test was performed. Values are
expressed as median and interquartiles.
P  0.05 was considered significant. Statistical analyses
were calculated with PASW 19 for OSX (SPSS Inc., Chi-
cago, IL). Graphs were made with Graphpad Prism 5 for
Macintosh (Graphpad Software, La Jolla, CA).
Results
Isolation of Neutrophils
The isolation procedure yielded neutrophils with a purity of
more than 94% with less than 1% of dead cells (defined as
7-AAD cells) and less than 2.5% of apoptotic cells (defined
as 7-AAD-/Annexin cells). No artificial activation of neu-
trophils occurred.
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Volatile Anesthetics Reduce Release of Neutrophilic MMP-9
Stimulation of neutrophils under control conditions (air/5%
CO2) with 100 nM IL-8 for 15 min lead to a significant
increase in MMP-9 (fig. 1A; control vs. air  IL-8, P 
0.005). When preconditioned with 2.2% of sevoflurane or
6% of desflurane for 45 min, release of MMP-9 upon stimu-
lation was completely blunted. Compared with IL-8 stimula-
tion with an air/5%CO2-mixture incubation, preconditioning
with volatile anesthetics decreased release ofMMP-9 upon IL-8
stimulation by 41% (13, 5%) and 40% (13%), respectively
(air  IL-8 vs. sevo  IL-8, P  0.007, air  IL-8 vs. des 
IL-8, P 0.001). A comparable effect of preconditioning was
also observed with reduced concentrations of volatile anesthetic
of 1.1% sevoflurane or 3% desflurane (fig. 1B; air  IL-8 vs.
sevo IL-8/desIL-8, P 0.001).
Enzymatic Activity of MMP-9 Corresponds to MMP-9
Protein Expression
To quantify enzymatic activity of MMP-9, zymography was
performed. Enzymatic activity was influenced by precondi-
tioning with volatile anesthetics comparable with the effect
onMMP-9 protein (fig. 1C, median and interquartile range;
control 1.0 [0], air  IL-8 1.76 [0.29], sevo  IL-8 1.19
Fig. 1. (A) Matrix metalloproteinase-9 (MMP-9) release from neutrophils. Neutrophils were preconditioned with 2.2% sevoflu-
rane (sevo  interleukin-8 [IL-8]), 6% desflurane (des  IL-8), or an air/5% CO2 mixture (air  IL-8) for 45 min at 37°C.
Neutrophils were then moved to an air/5% CO2-flooded incubator free of volatile anesthetics and stimulated with 100 nM IL-8
for 15 min. Data from three separate experiments, each sample repeated in duplicate, are given (n  6 for each variable). Bars
show mean and SD. Control refers to neutrophils that were exposed to air/5%CO2 during preconditioning and stimulated for
15 min with phosphate-buffered saline instead of IL-8. *P  0.01 for control versus air  IL-8, #P  0.01 for air  IL-8 versus
sevo  IL-8/des  IL-8. (B) Preconditioning with reduced volatile concentrations. Neutrophils were preconditioned with 1.1%
sevoflurane (sevo  IL-8), 3% of desflurane (des  IL-8), or an air/5% CO2 mixture (air  IL-8) followed by stimulation with IL-8
for 15 min. Data from three separate experiments, each sample repeated in duplicate, are given (n  6 for each variable). Bars
show mean and SD. Control refers to neutrophils exposed to air/5% CO2 during preconditioning followed by stimulation with
phosphate-buffered saline instead of IL-8. *P  0.001 for control versus air  IL-8, #P  0.001 for air  IL-8 versus sevo 
IL-8/des  IL-8. (C) Enzymatic activity of MMP-9. Enzymatic activity of MMP-9 in supernatants from neutrophils following
preconditioning as described for Fig. 1A and stimulation with IL-8 was assessed by zymography. Data from three separate
experiments (n  3 for each variable) are presented. Control refers to neutrophils exposed to air/5% CO2 and stimulated for 15
min with phosphate-buffered saline instead of IL-8. P  0.083 for control versus air  IL-8/sevo  IL-8/des  IL-8.
(D) Representative zymography gel. The MMP-9 band was identified by their molecular weight (dark band represents marker
at 92 kDa) and human recombinant MMP-9 as loading control (outer right band, MMP-9). PMA  phorbol myristate acetate.
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[0.6], des  IL-8 1.26 [0.4]; P  0.083). A representative
zymography gel is shown in figure 1D.
Changes in Release of MMP-9 Are Not Because of
Cytotoxic Effect of Volatile Anesthetics
Neutrophil viability was assessed to exclude a cytotoxic effect
of preconditioning with volatile anesthetics. No differences
in 7-AAD negative cells were noted with viability rates more
than 92% in all groups (data not shown).
PKC-dependent Phosphorylation of ERK1/2 and Release
of MMP-9 Is Not Altered by Volatile Anesthetics
Direct stimulation of PKCwith PMA induced a strong phos-
phorylation of ERK1/2 in all groups (fig. 2A; control vs.
air PMA/sevo PMA/des PMA, P 0.001). Precon-
ditioning with volatile anesthetics did not influence ERK1/
2-phosphorylation through PKC (air  PMA vs. sevo 
PMA,18.6% [26.5%], P 0.37; air PMA vs. des
PMA, 19.5% [17.8%]; P  0.27). No difference was
noted between sevoflurane and desflurane preconditioning
(sevo PMA vs. des PMA, P  1.0).
As a consequence, preconditioning did not alter release of
MMP-9 from PMA-stimulated neutrophils (fig. 2B, air 
PMA vs. sevo  PMA, 5.2% [12.2%]; air  PMA vs.
des PMA,8.8% [25.6%], P  1.0).
Protection with Volatile Anesthetics Is Also Observed
Upon Activation of IL-8 Receptor CXCR2
Stimulation with 100 ng/ml of CXCL1 induced a 51%
(26.2%) increase in MMP-9 release (fig. 3, control vs. air
 CXCL1, P 0.002). Preconditioning with volatile anes-
thetics for 45 min before stimulation with CXCL1 signifi-
cantly reduced MMP-9 release by 29% (14.8%) and 42%
(10.7%), respectively (air  CXCL1 vs. sevo  CXCL1,
P  0.009; air CXCL1 vs. des  CXCL1, P  0.001).
Volatile Anesthetics Do Not Alter Expression of the IL-8
Receptor CXCR2
To further assess the role of IL-8 receptor CXCR2 in medi-
ating volatile anesthetic preconditioning, surface expression
of CXCR2 was quantified following exposure to volatile an-
esthetics. Neither sevoflurane nor desflurane altered CXCR2
expression (fig. 4).
Preconditioning Reduces Matrigel Permeability Through
MMP-9 Down-regulation
In the current study, higher MMP-9 levels following IL-8
stimulation lead to an increase in permeability of thematrigel
layer for neutrophils (fig. 5; control vs. air IL-8,31.5%
[36.5%], P  0.001). Preconditioning prevented this in-
crease and reduced neutrophil migration to unstimulated
levels (air IL-8 vs. sevo IL-8, P 0.011; air IL-8 vs.
des IL-8, P  0.001).
Preconditioning of Neutrophils Reduces Tumor Cell
Transmigration
Transmigration through extracellular matrix is required dur-
ing metastatic seeding. As preconditioning reduced the per-
meability of Matrigel for neutrophils, the impact on tumor
cell transmigration was evaluated. MC-38GFP cells, derived
frommouse colon carcinoma, were allowed to migrate in the
presence of neutrophils either with or without precondition-
ing. Stimulation of neutrophils strongly increased tumor cell
transmigration (fig. 6; control vs. airCXCL1, P 0.001).
Fig. 2. (A) Protein kinase C-dependent phosphorylation of
extracellular regulated kinase (ERK)1/2. Neutrophils were
preconditioned with volatile anesthetics for 45 min and then
stimulated with 100 nM phorbol myristate acetate (PMA) for 5
min in an air/5% CO2-flooded incubator. Phosphorylation of
ERK 1/2 was quantified by flow cytometry. Data from three
separate experiments, each sample repeated in duplicate,
are given (n  6 for each variable). Bars show mean and SD.
*P  0.001 for control versus air  PMA/sevo  PMA/des 
PMA. (B) Protein kinase C-dependent matrix metalloprotei-
nase-9 release. Following preconditioning, neutrophils were
stimulated with PMA for 5 min in an air/5% CO2-flooded
incubator. Data from three separate experiments, each sam-
ple repeated in duplicate, are given (n  6 for each variable).
Bars show mean and SD. *P  0.001 for control versus air 
PMA/sevo  PMA/des  PMA. Des  desflurane; MMP 
matrix metalloproteinase-9; phospho-ERK 1/2  dependent
phosphorylation of extracellular regulated kinase 1/2; PMA 
phorbol myristate acetate; Sevo  sevoflurane.
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Preconditioning of neutrophils reduced the number of trans-
migrated tumor cells through Matrigel to baseline levels (air
 CXCL1 vs. sevo CXCL1/des CXCL1, P  0.001).
Discussion
Metastatic disease is one of the main factors affecting survival
in patients with cancer.31 MMP-9 was demonstrated to be
correlated with tumor invasion and metastatic seed-
ing.10,11,32 This study provides evidence that precondition-
ing with sevoflurane or desflurane at clinically used concen-
trations reduces the release of MMP-9 from human
neutrophils in an in vitro model of reperfusion injury. The
effect by which volatile anesthetics reduce the release of
MMP-9 is located downstream of the IL-8 receptor CXCR2,
but upstream of PKC. Through down-regulation of
MMP-9, preconditioning also reduces the migration of neu-
trophils and the invasiveness of tumor cells across the extra-
cellular matrix.
Fig. 3. Stimulation of the interleukin-8 CXC-receptor-2 with
CXC-ligand 1 (CXCL1). Neutrophils were preconditioned with
2.2% sevoflurane (sevo  CXCL1), 6% desflurane (des 
CXCL1), or an air/5% CO2 mixture (air CXCL1), followed by
stimulation with 100 nM CXCL1 in an air/5% CO2-flooded
incubator. Data from three separate experiments, each sam-
ple repeated in duplicate, are given (n  6 for each variable).
Bars show mean and SD. *P  0.01 for control versus air 
CXCL1, #P  0.01 for air  CXCL1 versus sevo  CXCL1/
des  CXCL1. CXCL1  CXC-ligand 1; MMP  matrix met-
alloproteinase.
Fig. 4. Interleukin-8 CXC-receptor-2 (CXCR2). Neutrophils
were preconditioned with volatile anesthetics for 45 min,
followed by staining on ice with anti-CXCR2 antibodies for 30
min. Expression of CXCR2 was analyzed by flow cytometry.
Data from three separate experiments, each sample repeated
in duplicate, are given (n  6 for each variable). Bars show
mean and SD. Des  desflurane; Sevo  sevoflurane.
Fig. 5. Matrigel permeability. Neutrophils were precondi-
tioned and stimulated on Matrigel-coated migration filters.
Neutrophils were allowed to migrate for 2 h in an incubator
free of volatile anesthetics. Data from four separate experi-
ments, each condition repeated in quadruples, are given.
Outliers, defined as deviating more than 1 SD from the mean
of the group for each separate experiment, were excluded
from further analysis. Final number of samples in each vari-
able is given in the figure. Bars show mean and SD. *P 
0.001 for control versus air  interleukin-8 (IL-8), #P  0.05
for air  IL-8 versus sevo  IL-8/des  IL-8. Des  desflu-
rane; IL-8  interleukin-8; Sevo  sevoflurane.
Fig. 6. Invasion of MC-38 green fluorescent protein tumor
cells. Mouse neutrophils were preconditioned and stimulated
with CXC-ligand 1 (CXCL1). MC-38 green fluorescent protein
tumor cells were added and allowed to migrate for 6 h.
Scatter plot shows median from six separate migration filters
for each condition (n  6 for each condition). *P 0.001 for
control versus air  CXCL1, #P  0.001 for air  CXCL1
versus sevo  CXCL1/des  CXCL1. CXCL1  CXC-ligand
1; DAPI  diamidinophenylindole; Des  desflurane;
MC38GFP  MC-38 green fluorescent protein tumor cells;
Sevo  sevoflurane.
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The perioperative period is of great interest regarding the
risk for recurrence after surgery for colorectal cancer. Only
recently, circulating tumor cells measured postoperatively
were identified as independent predictors of recurrence of
colorectal cancer.33 To form metastasis, these tumor cells
need to extravasate from the bloodstream and migrate
through extracellular matrix and basement membrane.
MMP-9 promotes this process, first through direct degrada-
tion of extracellular matrix and then through the formation
of premetastatic niches.34 ReducingMMP-9-release through
preconditioning with volatile anesthetics might therefore
come just in time before circulating tumor cells seed to the
target organ.
This work demonstrates that preconditioning with vola-
tile anesthetics reduces the release of MMP-9 from IL-8-
stimulated neutrophils. The currently commercially avail-
able ELISA kits do not distinguish between the inactive
pro-MMP-9 and its active form, but rather measure total
MMP-9. MMP-9 concentrations in the current study corre-
lated to MMP-9 activity as evidenced by zymography, fur-
ther validating the ELISA results.
Volatile anesthetics were often demonstrated to attenuate
neutrophil activation in vitro19,21 and in vivo.17,18,35 The
observed attenuation of MMP-9 is unique since in contrast
to neutrophil surface molecules involved in activation and
adhesion such as integrins and selectins, MMP-9 is regulated
at the level of tertiary granule release, a subgroup of the
peroxidase-negative granules.36,37 IL-8 stimulates the release
of MMP-9 through activation of PKC, which in turn phos-
phorylates ERK1/2.12 The direct stimulation of PKC with
PMA led to a strong phosphorylation of ERK1/2 in our
setting. However, preconditioning did not affect this pro-
cess. Similarly, MMP-9 release from PMA-stimulated neu-
trophils was not altered by preconditioning with volatile an-
esthetics. We therefore conclude that volatile anesthetic
preconditioning does not directly interfere with tertiary
granule release, but rather affects stimulatory pathways up-
stream of PKC.
Most neutrophil responses to IL-8, such as cell adhesion
or release of primary granules, are triggered through activa-
tion of both IL-8 receptors CXCR1 and CXCR2.
In contrast, tertiary granule release was shown to rely
exclusively on activation of CXCR2.12 CXCL1 and IL-8
both belong to the family of CXC-cytokines. However,
CXCL1 binds to CXCR2 only.38 Accordingly, we found
that stimulation of CXCR2 with CXCL1 led to an increase
in MMP-9. Similarly to the combined activation of CXCR1
and CXCR2 with IL-8, MMP-9 release from CXCL1-stim-
ulated neutrophils was inhibited by the application of vola-
tile anesthetics. This suggests that CXCR1 is not necessary to
mediate the effect of preconditioning with volatile anesthet-
ics on tertiary granule release.
Only surface-boundCXCR2 is able to form ligand-recep-
tor complexes with IL-8 or CXCL1, resulting in internaliza-
tion of the complex and downstream signaling. But internal-
ization is also thought to act as a stop mechanism to reduce
neutrophil activity once the neutrophil reached the site of
inflammation.39 No differences in CXCR2 expression fol-
lowing volatile anesthetic preconditioning were found in the
current study. This argues against a direct interaction be-
tween the volatile anesthetic and CXCR2 that might have
triggered internalization of the receptor.
Downstream events following stimulation of CXCR2
with IL-8 include the rapid increase in intracellular cal-
cium.40 Intracellular calcium triggers a wide range of neutro-
phil responses in inflammation that are influenced by volatile
anesthetics, such as oxidative burst20,41 and integrin up-reg-
ulation and adhesion.19,42 In contrast to those, the release of
MMP-9 was demonstrated to be independent from changes
in intracellular calcium concentration.12 This suggests that
preconditioning with volatile anesthetics regarding tertiary
granule release is mediated through calcium-independent
pathways.
Finally, the biologic relevance of the observed differences
in MMP-9 release on the integrity of the extracellular matrix
was investigated.Matrigel is derived fromEngelbreth-Holm-
Swarm sarcoma and consists mostly of collagen IV, laminin,
and proteoglycans.26 It is widely used as an equivalent for
extracellular matrix when studying tumor invasion.25,27
MMP-9 degrades components of Matrigel, and the migra-
tion of invasive cells through Matrigel has previously been
shown to rely on MMP-9 expression.43,44 The current study
demonstrated that down-regulation ofMMP-9 by precondi-
tioning with volatile anesthetics reduced the number of neu-
trophils that were able to cross the extracellular matrix.
It seems reasonable that invasive tumor cells as well
should be influenced by different extents of extracellular ma-
trix degradation. This is supported by Sun et al., who dem-
onstrated that the migration of oral squamous cell carcinoma
cells throughMatrigel is almost completely dependent on the
tumors’ ability to secrete MMP-9, and failing to do so sup-
presses the transmigration process.45 Therefore, this investi-
gation focused on the MC38 cell line that is derived from
mouse colon cancer, as metastatic seeding for these tumor
cells was demonstrated to be dependent on MMP-9 expres-
sion.7 Neutrophil preconditioning hindered the subsequent
migration process and reduced the number of tumor cells
that successfully crossed the extracellular matrix barrier. This
experimental setup clearly underlines the functional conse-
quence of decreased neutrophilic MMP-9 secretion upon
exposure to volatile anesthetics in vitro.
The use of Matrigel is currently the most common model
for studying tumor invasion in vitro. This is mostly because
of the lack of tissue preparation heterogeneity that is ob-
served with other substrates such as amnion or chorioallan-
toic membranes, resulting in difficult reproducibility of these
models. Although routinely used, there might be additional,
unknown components of extracellularmatrix that are lacking
in theMatrigel preparation. Therefore, further in vivo studies
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are clearly warranted before making clinical conclusions of
Matrigel-derived invasion studies.
In vitro studies on volatile anesthetics face two problems:
first, standard concentrations for volatile anesthetics are usu-
ally defined according to the patient’s response to the anes-
thetic, and might not be simply transferable to cell experi-
ments. In the current study it was decided to adhere to the
clinically most relevant concentrations of 0.5 or 1 minimum
alveolar concentration, as used by many other authors as
well.19,20 Second, the experimental setup of exposure to vol-
atile anesthetics might influence the absolute concentration
of anesthetic that can reach the cells. However, the current
method of cell exposure to volatile anesthetics is a well-estab-
lished procedure in our lab that has yielded well reproducible
results.46–49
In conclusion, this study demonstrates that volatile anes-
thetics attenuate IL-8-induced MMP-9 release from tertiary
granules downstream of CXCR2 and reduce the migratory
behavior of neutrophils in Matrigel. Consequently, the inva-
sive behavior of tumor cells facilitated through neutrophils
has been abrogated. Although these first in vitro results are
promising, further studies are warranted to evaluate the role
of volatile anesthetics in tumor cell migration and spreading
in vivo.
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